Wolverine Trading, LLC Aerie Pharmaceuticals Inc Put Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $57,420 - $106,256	-11,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.64 - $9.8 $65,423 - $113,680	11,600 New	11,600 $107,000
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $122,382 - $169,182	-11,700 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $79,200 - $106,458	-6,600 Reduced 36.07%	11,700 $174,000
Q1 2020 May 11, 2020	BUY	$11.84 - $25.52 $60,384 - $130,152	5,100 Added 38.64%	18,300 $247,000
Q4 2019 Feb 12, 2020	SELL	$17.72 - $25.1 $391,612 - $554,710	-22,100 Reduced 62.61%	13,200 $306,000
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $145,439 - $221,200	7,900 Added 28.83%	35,300 $718,000
Q2 2019 Aug 20, 2019	BUY	$28.97 - $48.21 $347,640 - $578,520	12,000 Added 77.92%	27,400 $810,000
Q1 2019 May 15, 2019	BUY	$36.32 - $49.25 $348,672 - $472,800	9,600 Added 165.52%	15,400 $732,000
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $6,600 - $12,008	-200 Reduced 3.33%	5,800 $206,000
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $336,900 - $443,400	6,000 New	6,000 $369,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.